Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events

被引:26
|
作者
Pagnamenta, Alberto [1 ,2 ]
Rabito, Giovanni [3 ]
Arosio, Alessandra [3 ]
Perren, Andreas [1 ,2 ]
Malacrida, Roberto [1 ,2 ]
Barazzoni, Fabrizio [4 ]
Domenighetti, Guido [1 ,2 ]
机构
[1] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Bellinzona, Switzerland
[2] EOC, Dept Intens Care Med, Intens Care Units Reg Hosp Mendrisio, Lugano, Switzerland
[3] Reg Hosp Locarno, Div Qual Improvement & Risk Management, Locarno, Switzerland
[4] EOC, Med Area Unit, Bellinzona, Switzerland
来源
关键词
Adverse events; Medical errors; Patient safety; Quality improvement; Intensive care; Reliability; PATIENT SAFETY; QUALITY IMPROVEMENT; MEDICATION ERRORS; PHARMACISTS; FRAMEWORK; OUTCOMES;
D O I
10.1186/2110-5820-2-47
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Adverse events (AEs) frequently occur in intensive care units (ICUs) and affect negatively patient outcomes. Targeted improvement strategies for patient safety are difficult to evaluate because of the intrinsic limitations of reporting crude AE rates. Single interventions influence positively the quality of care, but a multifaceted approach has been tested only in selected cases. The present study was designed to evaluate the rate, types, and contributing factors of emerging AEs and test the hypothesis that a multifaceted intervention on medication might reduce drug-related AEs. Methods: This is a prospective, multicenter, before-and-after study of adult patients admitted to four ICUs during a 24-month period. Voluntary, anonymous, self-reporting of AEs was performed using a detailed, locally designed questionnaire. The temporal impact of a multifaceted implementation strategy to reduce drug-related AEs was evaluated using the risk-index scores methodology. Results: A total of 2,047 AEs were reported (32 events per 100 ICU patient admissions and 117.4 events per 1,000 ICU patient days) from 6,404 patients, totaling 17,434 patient days. Nurses submitted the majority of questionnaires (n = 1,781, 87%). AEs were eye-witnessed in 49% (n = 1,003) of cases and occurred preferentially during an elective procedure (n = 1,597, 78%) and on morning shifts (n = 1,003, 49%), with a peak rate occurring around 10 a. m. Drug-related AEs were the most prevalent (n = 984, 48%), mainly as a consequence of incorrect prescriptions. Poor communication among caregivers (n = 776) and noncompliance with internal guidelines (n = 525) were the most prevalent contributing factors for AE occurrence. The majority of AEs (n = 1155, 56.4%) was associated with minimal, temporary harm. Risk-index scores for drug-related AEs decreased from 10.01 +/- 2.7 to 8.72 +/- 3.52 (absolute risk difference 1.29; 95% confidence interval, 0.88-1.7; p < 0.01) following the introduction of the intervention. Conclusions: AEs occurred in the ICU with a typical diurnal frequency distribution. Medication-related AEs were the most prevalent. By applying the risk-index scores methodology, we were able to demonstrate that our multifaceted implementation strategy focused on medication-related adverse events allowed to decrease drug related incidents.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events
    Alberto Pagnamenta
    Giovanni Rabito
    Alessandra Arosio
    Andreas Perren
    Roberto Malacrida
    Fabrizio Barazzoni
    Guido Domenighetti
    Annals of Intensive Care, 2
  • [2] THE IMPACT OF AN EVENT REPORTING SYSTEM ON THE PREVALENCE OF ADVERSE EVENTS IN INTENSIVE CARE UNITS
    Yousuf, Aneeq Muhammad
    Masud, Faisal
    Ratnani, Iqbal
    Faisal, Annum
    CRITICAL CARE MEDICINE, 2020, 48
  • [3] Adverse drug event reporting in intensive care units: A survey of current practices
    Kane-Gill, Sandra L.
    Devlin, John W.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) : 1267 - 1273
  • [4] Polypharmacy and adverse drug-related events
    Everett, WW
    ANNALS OF EMERGENCY MEDICINE, 2003, 41 (02) : 278 - 279
  • [5] Adverse drug events in intensive care units: Risk factors, impact, and the role of team care
    Kane-Gill, Sandra L.
    Jacobi, Judith
    Rothschild, Jeffrey M.
    CRITICAL CARE MEDICINE, 2010, 38 : S83 - S89
  • [6] Parental reporting of adverse drug events and other drug-related problems in children in Finland
    L. Lindell-Osuagwu
    K. Sepponen
    S. Farooqui
    H. Kokki
    K. Hämeen-Anttila
    K. Vainio
    European Journal of Clinical Pharmacology, 2013, 69 : 985 - 994
  • [7] Parental reporting of adverse drug events and other drug-related problems in children in Finland
    Lindell-Osuagwu, L.
    Sepponen, K.
    Farooqui, S.
    Kokki, H.
    Hameen-Anttila, K.
    Vainio, K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 985 - 994
  • [8] Polypharmacy and adverse drug-related events - In reply
    Hohl, CM
    ANNALS OF EMERGENCY MEDICINE, 2003, 41 (02) : 279 - 279
  • [9] Costs of adverse events in intensive care units
    Kaushal, Rainu
    Bates, David W.
    Franz, Calvin
    Soukup, Jane R.
    Rothschild, Jeffrey M.
    CRITICAL CARE MEDICINE, 2007, 35 (11) : 2479 - 2483
  • [10] Drug-Related Adverse Events of Osteoporosis Therapy
    Khan, Moira
    Cheung, Angela M.
    Khan, Aliya A.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2017, 46 (01) : 181 - +